ROCHESTER, NY and DUBAI, UAE, Feb. 17, 2023 – On March 1, Resiliélle Cosmetics, LLC and Regenerelle Biotherapeutics will unveil their new Resiliélle brand topical exosome cosmetics product manufactured by Regenerelle and exclusively distributed worldwide by Resiliélle. Resiliélle’s product will set a new standard for skin rejuvenation and lustrous hair. For optimal results, aesthetics professionals may use Resiliélle topically after microneedling or laser treatments. Resiliélle believes that the use of our topical exosome cosmetics will allow MedSpa, Dermatology and Plastic Surgery patients to use Resiliélle topical exosome cosmetics that have been developed to help patients to Leap Back In Time™ — At Any Age.™
In advance of the Dubai Derma Conference, Resiliélle is proud to announce that it has selected Great Look Medical Supplies, LLC as its first exclusive national distributor for the UAE market. As a part of their distribution agreement, Great Look has agreed to purchase $2.85 US million dollars’ worth of Resiliélle’s topical exosome product supplied in glass vials each containing 5 billion pure exosomes packaged in an off-the-shelf saline solution for easy use.
There are many types of stem cells and exosomes derived from many sources. Multiple recent scientific clinical trials and studies have found that of all stem cell sources, Wharton’s Jelly Stem Cells are the most potent source of both stem cells and exosomes, since they are derived from “zero-aged” stem cells collected from donated umbilical cords, obtained from healthy live births. No other source of stem cells can exceed the power, safety or quality of Regenerelle’s “immune privileged” Wharton’s Jelly stem cells from which they derive the exosomes that Resiliélle successfully formulated into the extraordinary cosmetic products they offer.
Stem cell-derived exosomes, like the exosomes in Resiliélle’s topical cosmetics product, are cell-free vesicles secreted by stem cells. Exosomes have been found to play a pivotal role in cell-to-cell communication due to the functional proteins which they carry. Stem cell-derived exosomes constitute a highly effective tool to cosmetic dermatology. The performance of stem cell-derived exosomes in regulating skin physiological and pathobiological functions suggests that stem cell-derived exosomes have remarkable potential in cosmetic dermatology.
In a January 27, 2023 article in realself ® news, authored by Karyn Repinski, “9 Doctors Predict the Biggest Aesthetic Trends for 2023” [https://www.realself.com/news/2023-aesthetic-trend-predictions], Dr. Jessie Cheung, a prominent board-certified dermatologist in Chicago and New York City, predicted, “An explosion in exosome therapy.”
Dr. Cheung said, “Forget about PRP—exosome therapy is the hottest tool in regenerative medicine…Exosomes, which are secreted by stem cells, contain hundreds more growth factors than PRP, and with more anti-inflammatory properties. They can be applied topically after microneedling or lasering, and there are ongoing studies for injectable use. Clinical studies have shown 180% increased elastin production, 300% fibroblast proliferation, six times more collagen production, and a significant reduction in downtime…”
Erin Crowley Ellis, the newly appointed CEO of Resiliélle, a woman-owned company, points out that “Looking fresher, healthier, brighter and more youthful is an easily attainable goal for everyone using our practical and effective topical exosome cosmetic skin care and hair revitalization solutions, which is why we teamed up with Regenerelle, the world’s largest and highest quality manufacturer of Wharton’s Jelly-derived stem cells and exosomes. I am thrilled to help improve our customers’ lives through proven formulations that make the best quality in skin care accessible and convenient, with offerings that address all of the concerns that we all have because of the combined impact of aging and the never-ending damaging effects of sun.”
Haisam Hawash, Managing Director BSB, MBA of Great Look Medical Supplies, explains why his company wants to offer Resiliélle to their clients: “Our exclusive UAE distribution agreement with Resiliélle offers our aesthetics patients a new and highly potent solution to vastly improve upon existing formulas used with microneedling and laser treatment, and we’re thrilled to expand into a new product category for our existing aesthetics medical equipment clients, plus the many other MedSpas, Dermatologists and Plastic Surgeons who will want to access the best topical exosome cosmetics product that has ever been offered in the UAE.” Furthermore, he noted, “Proven to be safe, potent, and extensively tested by CLIA-certified clinical laboratories in the USA, these high-quality, effective topicals cosmetic solutions are scientifically formulated and rigorously tested at the peak of industry standards, and the new line represents the latest innovation in Great Look’s growing portfolio of product offerings.”
“We are excited to introduce Resiliélle’s Age-Zero topical exosomes to the UAE market with our strategic distribution partner, Great Look Medical Supplies. Our team has the honor of speaking at the world-renowned Derma Dubai 2023 Conference on March 1st. Derma Dubai is the perfect stage to debut Resiliélle and discuss what defines a best-in-class exosome cosmetic product,” said Crowley Ellis.
Resiliélle topical exosome products are now available in the USA by exosome clinical consultants.
Both Resiliélle and Regenerelle are wholly owned subsidiaries of The Crowley Center for Regenerative & Biotherapeutics funded, commercialized and launched by Rochester, NY-based AT Venture Center https://www.atventurecenter.com/
For more information on these new offerings, please visit https://www.resilielle.com/ or, in the UAE, https://www.greatlookinc.com/en
For more information about Regenerelle’s regenerative and biotherapeutics products, go to https://www.regenerellestemcells.com/